Drug Shortages Update

["U.S. Food & Drug Administration (FDA)" <fda@xxxxxxxxxxxxxxxxxxxxxxx>]

Title: Drug Shortages Update

You are subscribed to Drug Shortages for U.S. Food & Drug Administration (FDA). This information has recently been updated.

February 19, 2013 

• Current Drug Shortages Index (updated)
  • Drugs to be Discontinued: Flurazepam Hydrochloride Capsules, USP C-IV 15mg
  • Drugs to be Discontinued: Flurazepam Hydrochloride Capsules, USP C-IV 30mg
  • Drugs to be Discontinued: Hydrochlorothiazide Tablets, USP 50mg
  • Drugs to be Discontinued: Hydroxychloroquine Sulfate Tablets, USP 200mg
  • Drugs to be Discontinued: Lithium Carbonate Capsules USP, 300mg
  • Drugs to be Discontinued: Lithium Carbonate Capsules USP, 300mg
  • Drugs to be Discontinued: Lithium Carbonate Capsules USP, 300mg
  • Drugs to be Discontinued: Naproxen Sodium Tablets USP, 550mg
  • Drugs to be Discontinued: Trihexyphenidyl Hydrochloride Tablets, USP 2mg

---

Subscriber Services:
Manage Preferences  |  Unsubscribe  |  Help with this service

Stay Connected:

---

This email was sent to list-fda@xxxxxxxxxxx using GovDelivery, on behalf of: U.S. Food & Drug Administration (FDA) · 10903 New Hampshire Ave · Silver Spring, MD 20993 · 800-439-1420